Trending Now
Moderna Inc (NASDAQ: MRNA) Demonstrates Improved Immune Response In Adolescents In...
Moderna Inc (NASDAQ: MRNA) demonstrated the safety of its COVID-19 vaccine in adolescents.
The company conducted a phase 2/3 clinical trial of its COVID-19 vaccine...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Activist Investing LLC Buys Common Stock From Titan Pharmaceuticals, Inc. (NASDAQ:...
Activist Investing LLC has announced the acquisition of Titan Pharmaceuticals, Inc's. (NASDAQ: TTNP) common stock. According to Activist Investing’s CEO, David E. Lazar. The...
MAKE IT MODERN
LATEST REVIEWS
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, has announced a significant new phase of financing to boost its development...
MAKE IT MODERN
PERFORMANCE TRAINING
Sesen Bio (NASDAQ: SESN) Expands Management Team Ahead of Potential Vicineum Approval
Sesen Bio (NASDAQ: SESN) is expanding its leadership team as it gears for its transformation into a commercial-phase business with the appointment of Amy...
Vaxart Inc. (NASDAQ: VXRT) Commences Phase II Clinical Trial For its Experimental Oral COVID-19...
A study by Duke University Published in bioRxiv has indicated that Vaxart Inc.’s (NASDAQ: VXRT) experimental oral tablet vaccine can reduce airborne SARS-CoV-2 virus...
IDEAYA Biosciences Inc. (NASDAQ:IDYA) And GlaxoSmithKline Plc (NYSE:GSK) In Strategic Partnership For Synthetic Lethality...
IDEAYA Biosciences Inc. (NASDAQ:IDYA) has announced a strategic partnership with GlaxoSmithKline Plc (NYSE:GSK) in Synthetic lethality, which is an emerging Oncology field.
IDEAYA’s Synthetic Lethality...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Announces the FDA’s Acceptance of Supplemental NDAs for TRIKAFTA, SYMDEKO,...
Despite having made a name in the pharmaceutical industry, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has continued to invest in scientific innovation and transformative medicines for...
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
Precision BioSciences Inc. (NASDAQ:DTIL) has announced that it has received Fast Track Designation from the FDA for PBCAR269A in treating refractory/relapsed multiple myeloma.
Fast Track...
MAKE IT MODERN
